Slingshot members are tracking this event:
Phase 3 Studies of Tanezumab for Chronic Pain Resume After Partial Clinical Hold
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Mar 23, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Chronic Pain, Tanezumab, Phase 3 Study, Partial Clinical Hold